Digitalisation to help pharma firms cut costs
Listen to article
Pakistan Single Window (PSW) CEO Syed Aftab Haider has said that digitalisation of regulatory processes will simplify compliance requirement and help pharmaceutical firms to reduce the time and cost of doing business and become more competitive in the global supply chain.
"PSW remains committed to leveraging innovative solutions to establish a globally integrated healthcare framework," he said, while highlighting the transformative impact of DRAP Clearance Gateway.
PSW and the Drug Regulatory Authority of Pakistan (Drap) officially launched the Drap Clearance Gateway at a ceremony in Islamabad.
The gateway, termed a milestone for the pharmaceutical industry, is a cutting-edge digital platform aimed at streamlining regulatory compliance, eliminating inefficiencies and providing real-time transparency across the supply chain.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
a day ago
- Business Recorder
‘ST imposition under EFS will sabotage export industry'
FAISALABAD: Addressing at a press conference, Senior Vice Chairman of the Pakistan Hosiery Manufacturers & Exporters Association (PHMA), Hazar Khan, warned that the imposition of sales tax at the import stage under the Export Facilitation Scheme (EFS) will sabotage the export industry. He cautioned that the government's move to impose sales tax at the import stage within the EFS framework would be another severe blow to apparel and textile exporters, who are already under immense financial pressure. He emphasised that the collection and refund process of sales tax is not only inefficient but also provides opportunities for corruption through fake refunds, while genuine exporters face long delays in getting their refunds. The value-added textile sector strongly believes that the EFS should be continued in its original form as it existed prior to Budget 2024-25, to ensure liquidity and transparency in the value chain. This stance is also supported by the inter-ministerial committee, led by the federal minister for Planning, under the directives of the prime minister. Chaudhry Salamat Ali, Group Leader of PHMA, stated that the EFS was developed through consultation with stakeholders and has streamlined, digitised, and improved the efficiency of the export process. Fully automated under WeBOC and PSW systems, the scheme has provided financial relief to exporters. He highlighted that APTMA is using outdated machinery with poor quality and high costs, while value-added garment production requires yarn that meets international standards. The government allowed yarn imports under EFS, which is a key reason for the increase in exports. Arif Ihsan Malik, former Chairman of APBUMA, mentioned that duty-free yarn imports have long been allowed under various SROs, similar to policies followed by Bangladesh, Vietnam, and other countries. He refuted APTMA's claim that 100 of their mills have shut down, calling it baseless and demanding that they share accurate data with the media. He also advocated for allowing commercial importers to bring in yarn under EFS so that small and medium-sized exporters can benefit as well. Mian Kashif Zia, former chairman of PHMA, said that the apparel industries in Bangladesh and Vietnam also rely on imported raw materials and their governments run similar facilitation schemes. Imposing sales tax under EFS would defeat its core purpose. Mian Farrukh Iqbal, former Chairman of PHMA, stated that the government has set a $60 billion export target under the 'Uraan' programme, which will be at risk if the EFS is withdrawn. He further claimed that APTMA produces substandard yarn which fails to meet international expectations, thus compromising the quality of garments made from it. Copyright Business Recorder, 2025
Express Tribune
08-05-2025
- Express Tribune
Sector-wide reforms initiated
The Cabinet Committee on Regulatory Reforms (CCoRR), in its first meeting at the Board of Investment, approved wide-ranging reforms across multiple sectors — including DRAP, NHA, PHA, FSC&RD. photo: file Listen to article The government is going to introduce a set of reforms in different sectors of the country to ensure ease of doing business. The Cabinet Committee on Regulatory Reforms (CCoRR) in its recent meeting agreed to a set of reforms to be introduced in the coming days. The first meeting of the Cabinet Committee on Regulatory Reforms (CCoRR) was held at the Board of Investment on May 6, 2025, in line with Prime Minister Shehbaz Sharif's vision to streamline Pakistan's regulatory landscape and improve the ease of doing business. The reforms are going to be introduced in multiple sectors including the Drug Regulatory Authority of Pakistan (DRAP), National Highway Authority (NHA), Pakistan Halal Authority (PHA), and the Federal Seed Certification and Registration Department (FSC&RD). One key proposal calls for DRAP to sign a Memorandum of Understanding (MoU) with the Intellectual Property Organisation of Pakistan (Pak-IPO) to ensure real-time data sharing related to trademark registration. Currently, a lack of coordination between the two entities has resulted in overlapping brand name claims. The proposed alignment would be in line with international best practices. The committee has also agreed that DRAP should adopt the principle of "obtain once, use multiple times" to eliminate the duplication of documents in its licensing processes. Additionally, the committee has directed the authority to prescribe fixed timelines for the evaluation and issuance of licenses, certificates, and permits. The cabinet body has also directed Islamabad Healthcare Regulatory Authority (IHRA) to outsource licensing and registration inspections of healthcare facilities to accredited third-party inspectors (TPIs) in a bid to reduce procedural delays. Mandatory inspections, which are currently handled in-house, have been cited as time-consuming and inefficient. In another move, IHRA has been directed to digitise its complaint management system to include businesses alongside patients, ensuring a more comprehensive and tech-enabled grievance redressal mechanism. Under the reforms, the PHA has been directed to revise its certification fee structure, which currently imposes a 0.025% turnover fee on businesses. The fee has been labelled as an indirect tax that discourages growth and hurts export competitiveness. The committee has agreed to exempt exporters from this fee and to automate and integrate the entire Halal certification process with the Pakistan Single Window (PSW) for enhanced efficiency. The committee has agreed to several reforms in Islamabad Capital Territory (ICT) under the Labour Welfare Department (LWD) and the Registrar of Firms (ROF): Currently, there is no defined timeline for boiler inspections during manufacturing unit registration. The committee has agreed to set a clear timeline, similar to India's 30-day inspection requirement. The factory registration process remains fully manual, requiring physical visits, extensive paperwork, and repeated follow-ups. ICT has proposed streamlining and digitising the system. CCORR is expected to review implementation strategy and financial requirements. The partnership firm registration process currently demands in-person appearances from all partners and witnesses. Authorities now proposed moving to a fully digital registration process. CCORR may direct ICT to set a specific implementation timeline. A proposal has been made to extend the validity of trade licenses, which are currently valid for only one year. Currently, trade licenses require annual renewals and mandatory inspections. The proposal involves extending the validity to three years to reduce the compliance burden. CCORR may issue formal instructions to implement this change.
Business Recorder
03-05-2025
- Business Recorder
BMP suggests uniform 1pc sales tax rate on all medicines
LAHORE: As the federal government enters the final phase of preparing the federal budget for 2025–26, the Federation of Pakistan Chambers of Commerce and Industry's (FPCCI) Businessmen Panel (BMP) has strongly urged the government to eliminate tax discrimination between different categories of medicines. The panel called for applying a uniform 1% sales tax rate on all medicines—whether allopathic, homeopathic, or herbal—to ensure fairness, accessibility, and consistency in healthcare taxation. The issue was discussed in detail during the meeting between Mian Anjum Nisar and a delegation from the Homeopathic Pharmac eutical and Chemist Association Pakistan (HPCA), who met him in the lead of Dr. Amanullah Bismil, Patron-in-Chief of the HPCA. The delegation included Dr. Ahsan Waris, Dr. Iqbal Hanif, Dr. Kashif Masood, and Saifurrahman Safi. The representatives shared their concerns regarding the unequal taxation structure, highlighting how it discourages the growth of the alternative medicine industry and limits consumer access to affordable treatment options. Chairman of the Businessmen Panel and former FPCCI president Mian Anjum Nisar pointed out that a significant disparity currently exists in the taxation system governing pharmaceutical and health-related products. Allopathic medicines—conventional pharmaceutical drugs—are taxed at a concessional rate of 1%, while homeopathic and herbal medicines are subject to a hefty 18% general sales tax (GST). This difference, he argued, is unjust and harmful, creating a disproportionate burden on consumers and manufacturers of non-allopathic medicines. 'The current tax system promotes inequality within the healthcare sector,' Anjum Nisar said. 'On the one hand, the government claims to prioritize public health and affordability; on the other hand, it penalizes manufacturers and users of homeopathic and herbal medicines with an unjustifiable tax rate. This contradictory policy undermines equitable healthcare access.' Dr. Bismil explained that the issue stems from outdated provisions in the Eighth Schedule of the Sales Tax Act, 1990, particularly Entry No. 81, which only refers to drugs registered under the now-repealed Drugs Act of 1976. That Act has since been replaced by the Drug Regulatory Authority of Pakistan (DRAP) Act, 2012, which regulates all therapeutic goods—allopathic, homeopathic, herbal, and nutraceutical. According to Section 32 of the DRAP Act, its provisions take precedence over earlier or conflicting laws. However, the sales tax framework has not been updated to reflect this change, resulting in a legal loophole that excludes non-allopathic medicines from receiving the same tax relief as allopathic drugs. Dr. Bismil urged the Ministry of Finance and the Federal Board of Revenue (FBR) to address this gap by amending the Eighth Schedule so that all DRAP-registered medicines are treated equally under the tax regime. He stressed that the amendment should be included in the Finance Bill 2025–26 and take effect from July 1, 2025. 'This is the ideal time to correct this policy anomaly,' said Dr. Bismil. 'As budget preparations are underway, the government must take this opportunity to demonstrate its commitment to inclusive healthcare, fair taxation, and support for local industries.' Anjum Nisar supported the delegation's demands and assured them he would take the issue to the highest level to seek a resolution. He emphasized that millions of Pakistanis—especially those in rural areas and low-income groups—rely on homeopathic and herbal treatments. By taxing these products at a higher rate, the government is restricting access for the underprivileged and effectively pushing patients toward more expensive alternatives. He further highlighted the economic potential of the alternative medicine sector, which has demonstrated remarkable resilience despite facing regulatory neglect and tax pressures. 'Pakistan has a rich heritage in traditional medicine systems, including homeopathy, Unani, and herbal formulations,' he said. 'If supported through progressive policy and tax fairness, these industries can contribute billions to the national economy and expand into export markets across the Middle East, Africa, and Asia.' Anjum Nisar added that a uniform 1% tax rate across all medicines would promote transparency, compliance, and a healthier business environment. It would allow all sectors of the healthcare industry to grow side by side, encouraging innovation and ensuring that patients have access to diverse treatment options at fair prices. He warned that maintaining the current dual tax system would continue to distort the market, discourage formalization, and hurt small- and medium-sized enterprises (SMEs) that make up the bulk of the homeopathic and herbal medicine industry. 'This is not just a tax issue—it's a healthcare issue and an economic opportunity,' Nisar concluded. 'The government must seize this moment to harmonize the taxation structure, promote equity in healthcare, and support the broader goal of industrial development in Pakistan.' Copyright Business Recorder, 2025
